Free Trial
NASDAQ:CERS

Cerus (CERS) Stock Price, News & Analysis

Cerus logo
$1.31 -0.02 (-1.50%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$1.28 -0.03 (-1.91%)
As of 08/27/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cerus Stock (NASDAQ:CERS)

Key Stats

Today's Range
$1.27
$1.33
50-Day Range
$1.16
$1.56
52-Week Range
$1.12
$2.35
Volume
529,072 shs
Average Volume
1.32 million shs
Market Capitalization
$251.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Consensus Rating
Buy

Company Overview

Cerus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

CERS MarketRank™: 

Cerus scored higher than 59% of companies evaluated by MarketBeat, and ranked 445th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cerus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cerus has received no research coverage in the past 90 days.

  • Read more about Cerus' stock forecast and price target.
  • Earnings Growth

    Earnings for Cerus are expected to grow in the coming year, from ($0.08) to ($0.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cerus is -13.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cerus is -13.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cerus has a P/B Ratio of 4.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cerus' valuation and earnings.
  • Percentage of Shares Shorted

    3.87% of the float of Cerus has been sold short.
  • Short Interest Ratio / Days to Cover

    Cerus has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Cerus has recently decreased by 5.14%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cerus does not currently pay a dividend.

  • Dividend Growth

    Cerus does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.87% of the float of Cerus has been sold short.
  • Short Interest Ratio / Days to Cover

    Cerus has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Cerus has recently decreased by 5.14%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Cerus has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Cerus this week, compared to 2 articles on an average week.
  • Search Interest

    Only 3 people have searched for CERS on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Cerus to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cerus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of Cerus is held by insiders.

  • Percentage Held by Institutions

    78.37% of the stock of Cerus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cerus' insider trading history.
Receive CERS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerus and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CERS Stock News Headlines

Cerus Director Makes Bold Stock Purchase!
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
See More Headlines

CERS Stock Analysis - Frequently Asked Questions

Cerus' stock was trading at $1.54 at the beginning of 2025. Since then, CERS shares have decreased by 14.9% and is now trading at $1.31.

Cerus Corporation (NASDAQ:CERS) posted its quarterly earnings results on Tuesday, August, 5th. The biotechnology company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The biotechnology company had revenue of $60.10 million for the quarter, compared to the consensus estimate of $51.80 million. Cerus had a negative trailing twelve-month return on equity of 33.77% and a negative net margin of 9.81%.
Read the conference call transcript
.

Top institutional shareholders of Cerus include ARK Investment Management LLC (10.05%), Wasatch Advisors LP (4.45%), Sumitomo Mitsui Trust Group Inc. (3.18%) and Nikko Asset Management Americas Inc. (3.16%). Insiders that own company stock include William Mariner Greenman, Vivek K Jayaraman, Kevin Dennis Green, Richard J Benjamin, Chrystal Jensen, Carol Moore, Chrystal Menard, Eric Bjerkholt, Daniel N Swisher Jr, Ann Lucena and Hua Shan.
View institutional ownership trends
.

Shares of CERS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cerus investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
8/05/2025
Today
8/27/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:CERS
CIK
1020214
Employees
290
Year Founded
1991

Price Target and Rating

High Price Target
$4.00
Low Price Target
$3.00
Potential Upside/Downside
+167.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.92 million
Net Margins
-9.81%
Pretax Margin
-9.66%
Return on Equity
-33.77%
Return on Assets
-9.32%

Debt

Debt-to-Equity Ratio
1.01
Current Ratio
2.00
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$192.51 million
Price / Sales
1.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
4.52

Miscellaneous

Outstanding Shares
191,699,000
Free Float
185,181,000
Market Cap
$251.13 million
Optionable
Optionable
Beta
1.55

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CERS) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners